The effect of food on the single dose pharmacokinetics of cediranib
Main Authors: | Jayson, G, Evans, T, Harris, A, Mitchell, C, Kelly, C, Middleton, M, Fielding, A, Laud, P, Robertson, J, Puchalski, T |
---|---|
Format: | Journal article |
Published: |
2008
|
Similar Items
-
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.
by: Mitchell, C, et al.
Published: (2011) -
Multi-center randomized phase II study comparing cediranib plus gefitinib with cediranib plus placebo in subjects with recurrent/progressive glioblastoma
by: Brown, N, et al.
Published: (2016) -
Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
by: Medinger, M, et al.
Published: (2009) -
Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy
by: Jianling Bi, et al.
Published: (2021-07-01) -
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
by: Batchelor, Tracy T., et al.
Published: (2014)